Toxin-producing yeast strains in the gut fuel inflammatory bowel disease
New expert clinical guidance issued on cardiovascular consequences of COVID-19
16 March 2022Study identifies key barriers to innovation among medical trainees
16 March 2022Toxin-producing yeast strains in the gut fuel inflammatory bowel disease
Individual Candida albicans yeast strains in the human gut are as different from each other as the humans that carry them, and some C. albicans strains may damage the gut of patients with inflammatory bowel disease (IBD), according to a new study from researchers at Weill Cornell Medicine. The findings suggest a possible way to tailor treatments to individual patients in the future.
